Table 1 Patient characteristics
From: Hypertension control and care at Mulago Hospital ambulatory clinic, Kampala-Uganda
Variable | Female n (%) | Male n (%) | Total n (%) |
|---|---|---|---|
Age categories (years) | |||
<40 | 36 (5.8) | 5 (5.2) | 41 (5.7) |
40–49 | 111 (17.9) | 15 (15.6) | 126 (17.6) |
50–59 | 172 (27.8) | 20 (20.8) | 192 (26.9) |
60–69 | 141 (22.8) | 18 (18.7) | 159 (22.2) |
70–79 | 121 (19.6) | 25 (26.0) | 146 (20.4) |
80 and above | 38 (6.1) | 13 (13.5) | 51 (7.1) |
Biophysical measurements done | |||
Weight | 234 (36.5) | 30 (30.3) | 264 (35.6) |
Height | 148 (22.7) | 20 (20.2) | 168 (22.7) |
WHR | 2 (0.3) | 0 | 2 (0.3) |
Investigations done | |||
Complete blood count | 231 (36.0) | 35 (35.4) | 266 (35.9) |
Urinalysis | 209 (32.6) | 34 (34.3) | 243 (32.8) |
Renal function tests | 292 (45.5) | 47 (47.5) | 339 (45.8) |
Chest X-ray | 114 (17.8) | 18 (18.2) | 132 (17.8) |
Echo | 284 (44.2) | 48 (48.5) | 332 (44.8) |
ECG | 290 (45.2) | 51 (51.5) | 341 (46.0) |
Medication | |||
ACEi or ARB | 464 (72.27) | 75 (75.76) | 539 (72.74) |
Beta blocker | 345 (53.7) | 42 (42.4) | 387 (52.2) |
Calcium channel blocker | 454 (70.7) | 82 (82.8) | 536 (72.3) |
Thiazide diuretic | 438 (68.2) | 70 (70.7) | 508 (68.6) |
Centrally acting vasodilator | 29 (4.5) | 7 (7.1) | 36 (4.9) |
Potassium sparing | 21 (3.3) | 3 (3.0) | 24 (3.2) |
Furosemide | 26 (4.1) | 13 (13.1) | 39 (5.3) |
Co-morbidity | 23 (23.3) | 67 (10.4) | 90 (12.2) |
Blood pressure control | 182 (28.4) | 16 (16.2) | 198 (26.7) |
Missed appointment | 301 (47.9) | 45 (46.4) | 346 (47.7) |